Biological Properties and Clinical Use of Calf Thymus Extract TFX-Polfa

  • Aleksander B. Skotnicki
  • Barbara K. Dabrowska-Bernstein
  • Marek P. Dabrowski
  • Andrzej Gorski
  • Jan Czarnecki
  • Julian Aleksandrowicz
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)


In the early 1970s, in searching for approaches which could reinforce immune responsiveness in our immunocompromised patients with aplastic or proliferative blood disorders, our attention became focused on the thymus gland. Previous studies on human fetal thymus transplantation in patients displaying various primary and acquired immunodeficiencies had proved to be partially successful in terms of immunorestoration and concomitant improvement of clinical status (August et al., 1968; Cleveland et al., 1968; Marcolongo and Di Paolo, 1973; Serrou, 1974; Stutzman et al., 1971).


Multiple Sclerosis Chronic Lymphocytic Leukemia Aplastic Anemia Chronic Active Hepatitis Primary Lung Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aleksandrowicz, J., 1977, Perspectives of thymotherapy and metalotherapy in hematology, Haematologica 62:98–118.PubMedGoogle Scholar
  2. Aleksandrowicz, J., and Skotnicki, A. B., 1976, The role of the thymus and thymic humoral factors in immunotherapy of aplastic and proliferative diseases of the haemopoietic system, Acta Med Pol. 17:1–17.PubMedGoogle Scholar
  3. Aleksandrowicz, J. and Skotnicki, A. B., 1982, Humoral thymotherapy in patients with primary and secondary immune deficiency states and bone marrow hypoplasia, in: Leukemia Ecology (J. Aleksandrowicz and A.B. Skotnicki, eds.), pp. 20–30, Natl. Cent. Sci. Tech. Econ. Inf., Warsaw.Google Scholar
  4. Aleksandrowicz, J., Rzepecki, W. M., Szmigiel, Z., Lukasiewicz, M., Skotnicki, A. B., and Lisiewicz, J., 1973, Preliminary results of thymus transplantation from myasthenia gravis patients to patients with leukemias and Hodgkin’s disease, Przegl. Lek. 30:518–522.PubMedGoogle Scholar
  5. Aleksandrowicz, J., Blicharski, J., Janicki, K., Lisiewicz, J., Skotnicki, A. B., Sliwczynska, B., Turowski, G., Szmigiel, Z., and Wazewska-Czyzewska, M., 1975a, Effect of the thymus extract on congenital hypogammaglobulinaemia and immunological deficiency accompanying the proliferative and aplastic haematological diseases, in: Biological Activity of Thymus Hormones (D.K. van Bekkum, ed.), pp. 37–39, Kooyker, Rotterdam.Google Scholar
  6. Aleksandrowicz, J., Turowski, G., Cybulski, L., Szmigiel, Z., and Skotnicki, A. B., 1975b, Immunohaematological and clinical response in patients with malignant diseases after repeated administration of thymus extract, Ann. Immunol. 7:97.Google Scholar
  7. Aleksandrowicz, J., Turowski, G., Czarnecki, J., Szmigiel, Z., Cybulski, L., and Skotnicki, A. B., 1975c, Thymic factor X (TFX) as a biologically active extract, Ann. Immunol. 7:97.Google Scholar
  8. Aleksandrowicz, J., Blicharski, J., Cichocki, T., Dobrowolski, J., Kwiatkowski, A., Lisiewicz, J., Sasiadek, U., Skotnicki, A. B., and Wazewska-Czyzewska, M., 1977, The effect of calf thymus extract on surface structure and lysosomal apparatus in lymphocytes of patients with chronic lymphocytic leukemia, Haematologica 63:267–276.Google Scholar
  9. Aleksandrowicz, J., Blicharski, J., Retinger, M., Skotnicki, A. B., and Zdunczyk, Z., 1981, Some aspects of immunopathogenesis of multiple sclerosis and therapeutic perspectives, Pol. Tyg. Lek. 13:1363–1365.Google Scholar
  10. August, C. S., Rosen, F. S., Filler, R. M., Janeway, C. A., Markowski, B., and Kay, H. E. A., 1968, Implantation of fetal thymus restoring immunological competence in patient with thymic aplasia (Di George’s syndrome), Lancet 2:1210–1211.PubMedCrossRefGoogle Scholar
  11. Cianciara, J., Gorska, E., Babiuch, L., Dabrowska-Bernstein, B. K., and Dabrowski, M. P., 1983, The immunomodulation treatment with TFX in patients with chronic active hepatitis, Cleveland, W. W., Fogel, B. J., Brown, W. T., and Kay, H. E. A., 1968, Fetal thymic transplant in a case of Di George’s syndrome, Lancet 2:1211–1212.Google Scholar
  12. Czarnecki, J., and Jaskolski, B., 1978, Preparation TFX-Polfa Jelenia Gora, Arch. Immunol. Ther.Exp. 26:475.Google Scholar
  13. Dabrowska-Bernstein, B. K., Dabrowski, M. P., Cianciara, J., Brzosko, W. J., Babiuch, L., and Kassur, B., 1980, The treatment of chronic aggressive hepatitis with Polish thymus factor (TFX), Erfahrungsheilkunde 29:71.Google Scholar
  14. Dabrowski, M. P., and Dabrowska-Bernstein, B. K., 1981, Diagnostic significance of the involvement of E-rosetting lymphocytes and monocytes in suppressive regulation of lymphocyte proliferative response in man, International Congress of Immunology, “Immunoregulation 81,” Urbino, Italy.Google Scholar
  15. Dabrowski, M. P., Dabrowska-Bernstein, B. K., Babiuch, L., and Brzosko, W. J., 1980a, Calf thymic hormone/TFX/driven maturation of human T-lymphocytes, 4th Intern. Congress Immunol., Paris, July, Abstracts, 17,2,05.Google Scholar
  16. Dabrowski, M. P., Dabrowska-Bernstein, B. K., Badmajew, W. P., Brzosko, W. J., 1980b, Quantitative estimation of human T-cell mediated suppressive activity, 4th International Congress of Immunology, Paris, Abstract 4.4.06.Google Scholar
  17. Dabrowski, M. P., Dabrowski-Bernstein, B. K., Brzosko, W. J., Babiuch, L., and Kassur, B., 1980c, Immunotherapy of patients with chronic virus B hepatitis. I. Maturation of human T-lymphocytes under influence of calf thymic hormone, Clin. Immunol. Immunopathol. 16:297–307.CrossRefGoogle Scholar
  18. Dabrowski, M. P., Dabrowska-Bernstein, B. K., Badmajew, W., Wasowska, B., Stasiak, A., Law-kowski, Z., and Brzosko, W. J., 1983, Concanavalin A induced cell activity in healthy donors and patients with calf thymus extract (TFX-Polfa): Mechanisms and simple method of estimation, Thymus (submitted).Google Scholar
  19. Gieldanowski, J., 1981, Immunomodulators—Thymus factor X (TFX) and levamisole in immune reactions and inflammatory processes, Arch. Immunol. Ther. Exp. 29:121–132.Google Scholar
  20. Gieldanowski, J., and Kowalczyk-Bronisz, S. H., 1978, Investigations on immunological and pharmacological activities of thymus factor X (TFX), Arch. Immunol. Ther. Exp. 26:485.Google Scholar
  21. Gieldanowski, J., Slopek, S., and Kowalczyk-Bronisz, S. H., 1980, Immunological and pharmalogical properties of thymus factor X (TFX). II. Immunotropic activity, Arch. Immunol. Ther. Exp. 28:853–857.Google Scholar
  22. Gorska, R., 1980, Studies of cellular and humoral immunity in recurrent aphthous stomatitis, Immunol. Pol. 5:291–295.Google Scholar
  23. Gorski, A., Skotnicki, A. B., Gaciong, Z., and Korczak, G., 1981, The effect of calf thymus extract TFX on mouse and human hemopoiesis, Thymus 3:129–141.PubMedGoogle Scholar
  24. Gorski, A., Korczak-Kowalska, G., Nowaczyk, M., Gaciong, Z., and Skopinska-Rozewska, E., 1982, Thymosin, an immunomodulator of antibody production in man, Immunology 47:497–501.PubMedGoogle Scholar
  25. Gorski, A., Paczek, L., Rancewicz, A., Mokrzycka-Michalik, M., Korczak-Kowalska, G., and Dierzanowska, D., 1983a, Factors affecting immunoglobulin production of lymphocytes from renal allograft recipients, Transplant. Proc. Google Scholar
  26. Gorski, A., Rancewicz, Z., Nowaczyk, M., Malejczyk, M., and Wasik, M., 1983b, Diminished synthesis of immunoglobulins by lymphocytes of patients treated with thymosin (TFX) and cyclophosphamide,Google Scholar
  27. Guglielmo, P., Giustolisi, R., Cacciola, E., and Milone, G., 1983, Immunomodulating treatment in patients with aplastic anemia, N. Engl. J. Med. 308:1362–1363.PubMedGoogle Scholar
  28. Jaszcz, W., Chlap, Z., Turowski, G., and Piotrowska, K., 1975, Studies on biologic activity of thymic extract (TFX). I. Effect on the blood picture and lymphatic organs in mice, Patol. Pol. 26:387–396.PubMedGoogle Scholar
  29. Jaszcz, W., Rzepecki, W., Wojciechowski, Z., and Piotrowska, K., 1980, The effect of TFX on the pictures of the blood and lymphatic organs of thymectomized mice in the post-neonatal period, Patol. Pol. 31:273–285.PubMedGoogle Scholar
  30. Jaszcz, W., Chlap, Z., Rzepecki, W., Szot, W., and Piotrowska, K., 1982, Evaluation of the effect of calf thymus extract (TFX) administration to transplantable-tumor bearing animals, Mater. Med. Pol. Google Scholar
  31. Kiczka, W., and Ozynski, R., 1983, Double blind control trial with calf thymus extract TFX in patients with acute B hepatitisGoogle Scholar
  32. Kiczka, W., Juszczyk, J., Adamek, J., and Zengteler, G., 1983, TFX in the treatment of chronic active hepatitis.Google Scholar
  33. Korczak-Kowalska, G., 1983, Thymosin (TFX) and suppressor cells of immunoglobulin production in man, Thymus Google Scholar
  34. Krzysko, R., and Slowik-Gabryelska, A., 1981, TFX in primary bronchial cancer and some indices of its activity, 6:223–230.Google Scholar
  35. Lehner, T., 1977, Progress report: Oral ulceration and Behcet’s syndrome, Gut 18:491–511.PubMedCrossRefGoogle Scholar
  36. Low, T. L. K., Mercer, R., Dahmberg, K., Czarnecki, J., and Skotnicki, A. B., Thymic factor X— TFX-Polfa: Biochemical characterization (in preparation).Google Scholar
  37. Marcolongo, R., and Di Paolo, N., 1973, Fetal thymic transplant in patients with Hodgkin’s disease, Blood 41:625–630.PubMedGoogle Scholar
  38. Marjanska-Radziszewska, J., Bicz-Ciecialowa, M., Szmigiel, Z., and Skotnicki, A. B., 1975, Application of the thymic extract in patients suffering from Hodgkin’s disease, XIth Congr. Pol. Haematol. Soc., Gdansk, Abstracts, p. 118.Google Scholar
  39. Rzepecki, W. M., Lukasiewicz, M., Aleksandrowicz, J., Szmigiel, Z., Skotnicki, A. B., and Lisiewicz, J., 1973, Thymus transplantation in leukemia and malignant lymphogranulomatosis, Lancet 2:508.PubMedCrossRefGoogle Scholar
  40. Rzepecki, W. M., Lukasiewicz, M., Aleksandrowicz, J., Szmigiel, Z., Skotnicki, A. B., and Lisiewicz, J., 1974, Thymus transplantation in leukemia and malignant lymphogranulomatosis, Lancet 1:990.PubMedCrossRefGoogle Scholar
  41. Serrou, B., 1974, Thymus transplantation in advanced cancer, Lancet 2:1290–1291.CrossRefGoogle Scholar
  42. Skotnicki, A. B., 1978, The biological activity and physicochemical properties of the thymus extract TFX, Pol. Tyg. Lek. 33:1119–1122.PubMedGoogle Scholar
  43. Skotnicki, A. B., 1979, Thymus extract in the treatment of aplastic anemia, Vth meeting of Int. Soc. Haematol., Hamburg, Abstracts III, p. 73.Google Scholar
  44. Skotnicki, A. B., 1980, Thymus extract—TFX—in the treatment of bone marrow hypoplasia, Erfahrungsheilkunde 29:73.Google Scholar
  45. Skotnicki, A. B., 1984, Immunoregulatory treatment in autoimmunoaggressive syndromes, Postepy Hig. Med. Dosw. (submitted).Google Scholar
  46. Skotnicki, A. B., Aleksandrowicz, J., and Czarnecki, J., 1975a, Immunopotentiation by thymic extract in human leukemia, IIIrd meeting of Int. Soc. Haematol., London, Abstracts, p. 46.Google Scholar
  47. Skotnicki, A. B., Aleksandrowicz, J., and Lisiewicz, J., 1975b, Effect of the calf thymus extract on immunologic reactivity in patients with hypogammaglobulinaemia, Boll. Ist. Sieroter. Milan. 54:500–501.Google Scholar
  48. Skotnicki, A. B., Thomson, A. E. R., and Tisdale, M. J., 1976, Influence of Polish TFX on levels of adenosine 3′: 5′ cyclic monophosphate (cAMP) in human lymphocytes, in: Scientific Report, p. 61, Imperial Cancer Research Fund, London.Google Scholar
  49. Skotnicki, A. B., Thomson, A. E. R., and Tisdale, M. J., 1978, The influence of calf thymus extract on lymphocyte populations in chronic lymphocytic leukemia, in: Immunotherapy of Malignant Diseases (H. Rainer, ed.), pp. 27–30, Schattauer, Stuttgart.Google Scholar
  50. Skotnicki, A. B., Gorski, A., Gaciong, Z., and Korczak, G., 1980, The effect of thymus extract on in vitro proliferation of hematopoietic progenitor cells, Fed. Proc. 39:4696.Google Scholar
  51. Skotnicki, A. B., Aleksandrowicz, J., Retinger-Grzesiula, M., Zdunczyk, A., Grochmal, S., and Huczynski, J., 1983a, Multiple sclerosis: Immune pathogeneis, up to date therapeutic strategy and the combined immunoregulatory treatment, Postepy Hig. Med. Dosw. Google Scholar
  52. Skotnicki, A. B., Blicharski, J., Lisiewicz, J., Sasiadek, U., Janik, J., Wolska, T., Zdunczyk, A., and Aleksandrowicz, J., 1983b, Calf thymus extract TFX-Polfa in the treatment of patients with secondary leukopenia: Therapy and drugs, (submitted).Google Scholar
  53. Skotnicki, A. B., Zatz, M. M., Gyorke, A., Seals, C., Cuddy, D., Low, T. L. K., Jacobs, R., Kind, P. H., and Molinari, G., Thymic factor X—TFX-Polfa: Biological properties, (manuscript in preparation).Google Scholar
  54. Slausen, D. O., Osburn, B. I., Skifrine, M., and Dungworth, D. L., 1975, Regression of feline sarcoma virus-induced sarcomas in dogs. I. Morphologic investigation, J. Natl. Cancer Inst. 54:361–370.Google Scholar
  55. Slopek, S., Szymaniec, S., and Bromirska, J., 1978, Evaluation of biological activity of TFX-Polfa, a product obtained from calf thymus, Arch. Immunol. Ther. Exp. 26:481–482.Google Scholar
  56. Slopek, S., Gieldanowski, J., and Kowalczyk-Bronisz, S. H., 1980, Immunobiological and pharmacological properties of thymus factor X (TFX). I. Biological and pharmacological activity, Arch. Immunol. Ther. Exp. 28:827–857.Google Scholar
  57. Slowik-Gabryelska, A., and Krzysko, R., 1980, The relationship between the dose of TFX and the clinical course of primary lung cancer, Pneumol. Pol. 48:187–195.Google Scholar
  58. Staroscik, K., Boratynski, J., and Lisowski, J., 1978, Properties of TFX, a product obtained from calf thymus, Arch. Immunol. Ther. Exp. 26:477–479.Google Scholar
  59. Stutzman, L., Mittelman, A., Onkochi, T., and Ambrus, J., 1971, Fetal thymus transplantation in Hodgkin’s disease, Proc. Am. Assoc. Cancer Res. 12:101–102.Google Scholar
  60. Svet-Moldavski, G. J., 1966, Is Hodgkin’s disease a syndrome of hypothymism?, Nature (London) 209:933–934.CrossRefGoogle Scholar
  61. Szmigiel, Z., Turowski, G., Rzepecki, W. M., Aleksandrowicz, J., and Skotnicki, A. B., 1975, The effect of myasthenic thymus fragment transplantation on the immune state of patients with proliferative and aplastic diseases of the haemopoietic system, Acta Med. Pol. 16:61–82.PubMedGoogle Scholar
  62. Thomson, A. E. R., Tisdale, M. J., and Skotnicki, A. B., 1979, The influence of Polish thymus extract “TFX” on lymphocytes in chronic lymphocytic leukemia, in: Scientific Report, pp. 85–86, Imperial Cancer Research Fund, London.Google Scholar
  63. Turowski, G., Cybulski, L., and Urban, A., 1975a, The first thymus extract administration to a patient with advanced cancer in: The Biological Activity of Thymic Hormones (D.W. van Bekkum, ed.), p. 41, Kooyker, Rotterdam.Google Scholar
  64. Turowski, G., Stachura, J., Kolodziej, J., Papla, B., and Wojcik, R., 1975b, Haematologic changes in rabbits under the influence of calf thymus extract (TFX), Patol. Pol. 26:379–386.Google Scholar
  65. Turowski, G., Cybulski, L., Politowski, M., Turaszwili, T., and Zubel, M., 1976, First trials of immunopotentiation by thymic extract (TFX) in surgical patients with malignant disease, Acta Med.Pol. 17:18–32.Google Scholar
  66. Urban, A., Turowski, G., and Cybulski, L., 1977, The histological changes of the stroma of colon and rectum cancers observed in patients after immunopotentiation by thymus extract (TFX), Patol. Pol. 28:47–59.PubMedGoogle Scholar
  67. Veys, E. M., Mielnats, H., Verbruggen, G., Dhondt, E., Goethals, L., Cheroutre, L., and Buelens, H., 1981, Levamisole as basic treatment of rheumatoid arthritis: Long term evaluation, J. Rheumatol. 8:45–56.PubMedGoogle Scholar
  68. Wazewska-Czyzewska, M., Aleksandrowicz, J., Turowski, G., Blicharski, J., Dobrowolski, J., and Dolezalowa, M., 1976, A trial of immunologic stimulation with thymic extract (TFX) in untreated chronic lymphocytic leukemia, Acta Med. Pol. 17:97–110.PubMedGoogle Scholar
  69. Wazewska-Czyzewska, M., Aleksandrowicz, J., Szybinski, Z., Kulig, D., Plonka, I., and Skotnicki, A. B., 1977, The effect of calf thymus extract (TFX) on the survival of mice exposed to ionizing radiation, Pol. Przegl. Radiol. Med. Nukl. 41:51–55.PubMedGoogle Scholar
  70. Zeromski, J., Slowik-Gabryelska, A., Krzysko, R., 1976, The preliminary evaluation of TFX administration in advanced bronchogenic carcinoma, Seminar on cellular and humoral immunity in lung diseases, Poznan, Abstracts, pp. 44–46.Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Aleksander B. Skotnicki
    • 1
  • Barbara K. Dabrowska-Bernstein
    • 1
  • Marek P. Dabrowski
    • 1
  • Andrzej Gorski
    • 1
  • Jan Czarnecki
    • 1
  • Julian Aleksandrowicz
    • 1
  1. 1.Hematology Department, Cracow Academy of Medicine, Institute of Infectious Diseases and Institute of TransplantationWarsaw Academy of Medicine, Polfa PharmaceuticalsJelenia GoraPoland

Personalised recommendations